Fibulin-2 is essential for angiotensin II-induced myocardial fibrosis mediated by transforming growth factor (TGF)-β
Authors:
Open Access
- 25 April 2016
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 96 (7) , 773-783
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Therapeutic Cardiac‐Targeted Delivery of miR‐1 Reverses Pressure Overload–Induced Cardiac Hypertrophy and Attenuates Pathological RemodelingJournal of the American Heart Association, 2013
- Matricellular Proteins in Cardiac Adaptation and DiseasePhysiological Reviews, 2012
- Loss of fibulin-2 protects against progressive ventricular dysfunction after myocardial infarctionJournal of Molecular and Cellular Cardiology, 2012
- Transforming Growth Factor β1 Oppositely Regulates the Hypertrophic and Contractile Response to β-Adrenergic Stimulation in the HeartPLOS ONE, 2011
- Transforming growth factor (TGF)-β signaling in cardiac remodelingJournal of Molecular and Cellular Cardiology, 2011
- Pivotal role of cardiomyocyte TGF-β signaling in the murine pathological response to sustained pressure overloadJournal of Clinical Investigation, 2011
- Inhibition of transforming growth factor-β signaling induces left ventricular dilation and dysfunction in the pressure-overloaded heartAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- Fibulin-2 Is Dispensable for Mouse Development and Elastic Fiber FormationMolecular and Cellular Biology, 2008
- Role of Osteopontin in Cardiac Fibrosis and Remodeling in Angiotensin II-Induced Cardiac HypertrophyHypertension, 2004
- Fibulin‐2 expression marks transformed mesenchymal cells in developing cardiac valves, aortic arch vessels, and coronary vesselsDevelopmental Dynamics, 2001